Iovance Biotherapeutics Inc (IOVA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.59B
Last updated: Nov 17, 2026 at 11:06 AM ET
Iovance Biotherapeutics Inc (IOVA) Government Contracts
Federal agencies obligated $0 to Iovance Biotherapeutics over the 12 months through Sep 30, 2026. Iovance Biotherapeutics had obligation activity on 1 federal contract over the same 12 months, all of them new. Agencies report contract actions with a delay, so the latest months, Jul to Sep 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.
Federal Obligations
Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.
- Obligations
- $0
- Obligations to revenue
- 0.0%
| Prior 12 months | $0 |
|---|---|
| Contracts with activity | 1 |
| New contracts | 1 |
|---|
12 months through Sep 30, 2026
Largest New Awards
| Award ID | Agency | Amount | Start | End | Description |
|---|---|---|---|---|---|
| 36C24826N0268 | Department of Veterans Affairs | $0 | Jan 5, 2026 | Apr 4, 2026 | AMTAGVI |
Monthly Obligations
The latest complete month, Jun 2026, had no net obligations. The largest month in the table was Jan 2026, at $393,366.
| Month | Obligations |
|---|---|
| Sep 2026 | $0 |
| Aug 2026 | $0 |
| Jul 2026 | $0 |
| Jun 2026 | $0 |
| May 2026 | $0 |
| Apr 2026 | -$393,366 |
| Mar 2026 | $0 |
| Feb 2026 | $0 |
| Jan 2026 | $393,366 |
| Dec 2025 | $0 |
| Nov 2025 | $0 |
| Oct 2025 | $0 |
| Month | Obligations |
|---|---|
| Sep 2025 | $0 |
| Aug 2025 | $0 |
| Jul 2025 | -$219,576 |
| Jun 2025 | $0 |
| May 2025 | $0 |
| Apr 2025 | $219,576 |
| Mar 2025 | $0 |
| Feb 2025 | $0 |
| Jan 2025 | $0 |
| Dec 2024 | $0 |
| Nov 2024 | $0 |
| Oct 2024 | $0 |
Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, Jul to Sep 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.
Frequently Asked Questions About IOVA
How much does Iovance Biotherapeutics receive in federal contracts?
Iovance Biotherapeutics had $0 in federal contract obligations over the 12 months through Sep 30, 2026, compared with $0 in the 12 months before. Obligations are contract bookings by the awarding agency, not recognized revenue.
What are Iovance Biotherapeutics' largest government contracts?
The largest new awards over the 12 months through Sep 30, 2026 were 36C24826N0268, Department of Veterans Affairs, $0, started Jan 5, 2026.
What new federal contracts did Iovance Biotherapeutics win in the 12 months through Sep 30, 2026?
Iovance Biotherapeutics won 1 new federal contract in the 12 months through Sep 30, 2026. The largest was 36C24826N0268, Department of Veterans Affairs, $0, started Jan 5, 2026.
How do Iovance Biotherapeutics' federal obligations compare with its revenue?
Federal contract obligations were $0 over the 12 months through Sep 30, 2026, equivalent to less than 1% of Iovance Biotherapeutics' revenue. Obligations are amounts the government committed to contracts in the period, not the share of Iovance Biotherapeutics' revenue that comes from the government.
IOVA pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts